Showing 331 to 345 of 1966 results
HCPC responds to COVID-19 Vaccines Delivery Plan
The UK Government published its COVID-19 Vaccines Delivery Plan on Monday 11th January.
HCPC response to consultation on patient group directions for ODPs
Health and Care Professions Council response to NHS England’s consultation on the proposal for the supply and administration of medicines using patient group directions for operating department practitioners across the United Kingdom
Freedom of Information Policy
The Freedom of Information Act 2000 (FOIA) enables anyone to request recorded information held by the Health and Care Professions Council (HCPC)
Fitness to practise annual report 2017
This report provides information about the HCPC’s work in considering allegations about the fitness to practise of HCPC registrants.
Key findings from the Year in Registration Survey 2023
Key findings from our year in registration survey, which aims to gather insight about how students’ education and training prepares them for practice.
HR Equality and Diversity Data 2019
All applicants for employee and partner roles at the HCPC are asked to complete a voluntary equal opportunities and diversity monitoring form.
Registration FAQs
Some of the questions we most frequently get asked by registrants
Update on the Indicative Sanctions Policy review
In early 2017, the HCPC commenced a review of the Indicative Sanctions Policy to ensure it is up to date, reflects public opinion, and continues to support fair and proportionate decision making. As part of this review we commissioned market research into the public’s views of the Policy and undertook a public consultation.
HCPC statement on guidance on health and character and suicidal ideation
Our priority is ensuring that registrants have access to advice and support, so that they can get the help they need and ensure they are able to continue to practise safely, without fear of the impact on their registration. To support this, we have produced online materials aimed at registrants and updated our guidance on health and character to include more illustrative case studies.
Reclassification of Gabapentin and Pregabalin
From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)
Consultation workshop: Standards of conduct, performance and ethics - equality diversity and inclusion
This workshop gives you an opportunity to ask questions about the revisions we have made
Consultation workshop: Standards of conduct, performance and ethics - communication with colleagues, service users and carers
This workshop gives you an opportunity to ask questions about the revisions we have made
Consultation workshop: Standards of conduct, performance and ethics - sustainability
This workshop gives you an opportunity to ask questions about the revisions we have made
Launch of consultation for the standards of conduct, performance and ethics
Today we have launched a consultation which outlines proposed changes to the Standards of conduct, performance and ethics.